RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin

Shuhui Zhang, Lin Zhou, Mengdi Zhang, Yuehua Wang, Mengqi Wang, Jincheng Du, Wenwen Gu, Fuguang Kui, Jiahuan Li, Shengnan Geng, Gangjun Du

Open source

DOI: 10.3389/fphar.2019.01658
Published: 2020-01-29
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2019.01658,
  title = {RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin},
  author = {Shuhui Zhang and Lin Zhou and Mengdi Zhang and Yuehua Wang and Mengqi Wang and Jincheng Du and Wenwen Gu and Fuguang Kui and Jiahuan Li and Shengnan Geng and Gangjun Du},
  year = {2020},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2019.01658},
  url = {https://doi.org/10.3389/fphar.2019.01658}
}

RIS

TY  - JOUR
TI  - RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
AU  - Shuhui Zhang
AU  - Lin Zhou
AU  - Mengdi Zhang
AU  - Yuehua Wang
AU  - Mengqi Wang
AU  - Jincheng Du
AU  - Wenwen Gu
AU  - Fuguang Kui
AU  - Jiahuan Li
AU  - Shengnan Geng
AU  - Gangjun Du
PY  - 2020
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2019.01658
UR  - https://doi.org/10.3389/fphar.2019.01658
ER  -

APA

Zhang, S., Zhou, L., Zhang, M., Wang, Y., Wang, M., Du, J., Gu, W., Kui, F., Li, J., Geng, S., & Du, G. (2020). RETRACTED: Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01658

Source records

crossref · retrieved 2026-09-24T19:49:42.502Z